Trials & Tribulations Removing barriers to cancer care in underserved communities October 29, 2021Vol.47 No.40By Dany Habr
Conversation with The Cancer Letter Michelle Le Beau: CPRIT will be “looking at everything” through a health equity lens in awarding billions of dollars in grants October 22, 2021Vol.47 No.39By Matthew Bin Han Ong
FreeObituary David M. Livingston, Dana-Farber scientist and former BSA chair, dies at 80 October 22, 2021Vol.47 No.39By Richard Saltus
Monica Bertagnolli, Nancy-Ann Min DeParle, Kathrin Jansen, Vivek Murthy, Drew Pardoll, Eric Rubin, Feng Zhang are among 100 new NAM members October 22, 2021Vol.47 No.39
Cancer History ProjectConversation with The Cancer LetterFree Susan Love on breast cancer activism in the 1990s October 22, 2021Vol.47 No.39By Alexandria Carolan
FreeIn the Archives Susan Love, Emil Freireich, James Holland on breast cancer October 22, 2021Vol.47 No.39
Trials & Tribulations A FLASH flood of research relating to ultra-high dose rate radiation therapy October 22, 2021Vol.47 No.39By Constantinos Koumenis and Amit Maity
Conversation with The Cancer Letter FDA’s review of “dangling indications” continues beyond PD-1 and PD-L1 drugs October 15, 2021Vol.47 No.38By Paul Goldberg
Cancer History ProjectFreeGuest Editorial Tackling health equity and Latinx representation in medicine as U.S. Hispanic population grows October 15, 2021Vol.47 No.38By Ana Maria López
FreeObituary Joseph R. Bertino made fundamental discoveries in oncology, was president of ASCO, AACR October 15, 2021Vol.47 No.38By Paul Goldberg
